Antipodes Partners’s Newmont NEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Hold
243,496
0.42% 51
2026
Q1
$26.4M Sell
243,496
-84,693
-26% -$9.76M 0.51% 48
2025
Q4
$32.8M Sell
328,189
-137,254
-29% -$12.4M 0.69% 44
2025
Q3
$39.2M Buy
465,443
+68,811
+17% +$4.8M 0.88% 38
2025
Q2
$23.1M Sell
396,632
-82,764
-17% -$4.42M 0.72% 32
2025
Q1
$23.1M Buy
479,396
+135,480
+39% +$5.95M 0.72% 32
2024
Q4
$12.8M Sell
343,916
-185,880
-35% -$8.47M 0.44% 37
2024
Q3
$28.3M Buy
529,796
+291,932
+123% +$14.5M 0.98% 33
2024
Q2
$9.96M Buy
237,864
+79,914
+51% +$3.27M 0.36% 35
2024
Q1
$5.66M Hold
157,950
0.18% 43
2023
Q4
$6.54M Sell
157,950
-11,371
-7% -$439K 0.2% 42
2023
Q3
$6.27M Sell
169,321
-3,637
-2% -$148K 0.2% 41
2023
Q2
$7.38M Buy
172,958
+92,852
+116% +$4.21M 0.25% 36
2023
Q1
$3.93M Buy
+80,106
New +$3.88M 0.14% 38

Other funds holding NEM

Antipodes Partners's NEM Position: Q2 2026 in Review

Antipodes Partners held its Newmont (NEM) position steady in Q2 2026 at 243,496 shares worth $22.7M. The position accounts for 0.42% of the portfolio, ranked #51.

Antipodes Partners first reported a position in NEM in Q1 2023 and has held it in 14 quarters since. The position peaked at $39.2M in Q3 2025. 1,779 funds tracked by Wall St. Rank hold NEM as of Q2 2026.

  • Antipodes Partners held 243,496 shares of Newmont worth $22.7M as of Q2 2026.
  • Antipodes Partners left its Newmont share count unchanged in Q2 2026.
  • Newmont made up 0.42% of Antipodes Partners's portfolio in Q2 2026, its #51 holding.
  • Antipodes Partners first reported a position in Newmont in Q1 2023 and has held it in 14 quarters since.
  • Antipodes Partners's Newmont position peaked at $39.2M in Q3 2025.
  • 1,779 funds tracked by Wall St. Rank held Newmont as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.